tiprankstipranks
Gland Pharma Ltd. (IN:GLAND)
:GLAND
India Market
GLAND
Gland Pharma Ltd.
RESEARCH TOOLSreports

Gland Pharma Ltd. (GLAND) Ratios

1 Followers

Gland Pharma Ltd. Ratios

IN:GLAND's free cash flow for Q2 2026 was ₹0.26. For the 2026 fiscal year, IN:GLAND's free cash flow was decreased by ₹ and operating cash flow was ₹0.20. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio
 4.13 4.33 4.04 9.46 10.05
Quick Ratio
 3.07 3.26 2.84 6.75 7.94
Cash Ratio
 1.58 1.63 0.26 2.62 0.54
Solvency Ratio
 0.55 0.51 0.57 1.13 1.96
Operating Cash Flow Ratio
 0.35 0.58 0.71 0.50 1.36
Short-Term Operating Cash Flow Coverage
 2.99 4.78 4.67 649.94 7.06K
Net Current Asset Value
₹ 48.08B₹ 47.09B₹ 37.08B₹ 60.82B₹ 51.76B
Leverage Ratios
Debt-to-Assets Ratio
 0.03 0.03 0.03 <0.01 <0.01
Debt-to-Equity Ratio
 0.03 0.03 0.04 <0.01 <0.01
Debt-to-Capital Ratio
 0.03 0.03 0.04 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
 <0.01 <0.01 0.01 <0.01 <0.01
Financial Leverage Ratio
 1.23 1.23 1.22 1.10 1.09
Debt Service Coverage Ratio
 5.02 4.02 3.91 94.60 206.06
Interest Coverage Ratio
 32.02 72.45 69.56 155.35 302.17
Debt to Market Cap
 <0.01 0.01 0.01 <0.01 <0.01
Interest Debt Per Share
 20.21 20.50 24.18 0.72 0.61
Net Debt to EBITDA
 -1.55 -1.82 0.01 -1.85 -0.21
Profitability Margins
Gross Profit Margin
33.80%56.16%54.92%48.70%48.89%
EBIT Margin
18.93%15.53%17.15%24.40%31.81%
EBITDA Margin
25.37%21.92%22.89%28.44%34.32%
Operating Profit Margin
16.08%30.94%32.17%31.92%35.99%
Pretax Profit Margin
20.40%18.92%19.99%29.10%36.78%
Net Profit Margin
13.86%12.44%13.64%21.55%27.53%
Continuous Operations Profit Margin
13.86%12.44%13.64%21.55%27.53%
Net Income Per EBT
67.93%65.73%68.21%74.06%74.86%
EBT Per EBIT
126.87%61.15%62.14%91.16%102.18%
Return on Assets (ROA)
7.18%6.22%7.25%8.90%15.47%
Return on Equity (ROE)
9.25%7.63%8.85%9.81%16.93%
Return on Capital Employed (ROCE)
9.74%17.99%19.68%14.37%21.84%
Return on Invested Capital (ROIC)
6.49%11.58%13.09%10.64%16.35%
Return on Tangible Assets
7.43%6.43%7.49%8.91%15.49%
Earnings Yield
2.95%2.73%2.59%3.74%2.25%
Efficiency Ratios
Receivables Turnover
 3.91 3.70 3.44 3.50 3.40
Payables Turnover
 4.38 3.00 2.96 3.17 4.86
Inventory Turnover
 2.23 1.46 1.52 0.94 1.83
Fixed Asset Turnover
 1.45 1.42 1.46 2.09 2.55
Asset Turnover
 0.52 0.50 0.53 0.41 0.56
Working Capital Turnover Ratio
 2.29 1.19 1.09 0.63 0.89
Cash Conversion Cycle
 173.70 226.76 222.48 377.34 231.57
Days of Sales Outstanding
 93.43 98.55 106.20 104.32 107.22
Days of Inventory Outstanding
 163.57 249.83 239.58 388.30 199.45
Days of Payables Outstanding
 83.30 121.62 123.29 115.29 75.10
Operating Cycle
 257.00 348.38 345.78 492.63 306.68
Cash Flow Ratios
Operating Cash Flow Per Share
 36.01 55.52 60.51 22.10 48.06
Free Cash Flow Per Share
 24.24 32.18 36.84 8.55 16.33
CapEx Per Share
 11.77 23.34 23.67 13.55 31.73
Free Cash Flow to Operating Cash Flow
 0.67 0.58 0.61 0.39 0.34
Dividend Paid and CapEx Coverage Ratio
 1.21 1.28 2.56 1.63 1.51
Capital Expenditure Coverage Ratio
 3.06 2.38 2.56 1.63 1.51
Operating Cash Flow Coverage Ratio
 1.96 2.92 2.68 81.74 166.72
Operating Cash Flow to Sales Ratio
 0.10 0.16 0.18 0.10 0.18
Free Cash Flow Yield
1.39%2.07%2.03%0.67%0.50%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 33.88 36.64 38.68 26.74 44.44
Price-to-Sales (P/S) Ratio
 4.69 4.56 5.27 5.76 12.24
Price-to-Book (P/B) Ratio
 3.00 2.80 3.43 2.62 7.52
Price-to-Free Cash Flow (P/FCF) Ratio
 71.87 48.27 49.24 148.28 200.44
Price-to-Operating Cash Flow Ratio
 48.38 27.98 29.98 57.38 68.10
Price-to-Earnings Growth (PEG) Ratio
 4.71 -3.82 -33.98 -0.75 2.61
Price-to-Fair Value
 3.00 2.80 3.43 2.62 7.52
Enterprise Value Multiple
 16.96 18.96 23.05 18.41 35.45
Enterprise Value
 262.97B 233.52B 298.95B 189.80B 535.37B
EV to EBITDA
 16.96 18.96 23.05 18.41 35.45
EV to Sales
 4.30 4.16 5.28 5.24 12.17
EV to Free Cash Flow
 65.86 44.04 49.26 134.76 199.28
EV to Operating Cash Flow
 44.33 25.53 29.99 52.15 67.70
Tangible Book Value Per Share
 556.52 533.96 508.04 482.60 434.25
Shareholders’ Equity Per Share
 580.39 555.44 529.56 483.30 435.01
Tax and Other Ratios
Effective Tax Rate
 0.32 0.34 0.32 0.26 0.25
Revenue Per Share
 371.01 340.92 343.86 220.11 267.46
Net Income Per Share
 51.42 42.40 46.89 47.43 73.64
Tax Burden
 0.68 0.66 0.68 0.74 0.75
Interest Burden
 1.08 1.22 1.17 1.19 1.16
Research & Development to Revenue
 0.05 0.00 0.00 0.06 0.05
SG&A to Revenue
 0.13 0.25 0.00 0.00 0.00
Stock-Based Compensation to Revenue
 <0.01 0.00 0.00 0.00 <0.01
Income Quality
 0.59 1.31 1.29 0.35 0.49
Currency in INR